A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions

Attention-Deficit Hyperactivity Disorder (ADHD)

Interventions

DRUG

PDC-1421 Capsule

PDC-1421 Capsule is a botanical investigational new drug containing the extract of Radix Polygalae (Polygala tenuifolia Willd.) as active ingredient.

Trial Locations (1)

UCSF Medical Center, San Francisco

All Listed Sponsors

lead

BioLite, Inc.

INDUSTRY

NCT02699086 - A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter